PuSH - Publikationsserver des Helmholtz Zentrums München

32 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Barahona Ponce, C.* et al.: Gallstones, body mass index, C-reactive protein and gallbladder cancer—Mendelian randomization analysis of chilean and European genotype data. Hepatology 73, 1783-1796 (2021)
2.
Riedl, T.* et al.: HIF1α-mediated RelB/APOBEC3B downregulation allows Hepatitis B Virus persistence. Hepatology, DOI: 10.1002/hep.31902 (2021)
3.
Brägelmann, J.* et al.: Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer. Hepatology, DOI: 10.1002/hep.31585 (2020)
4.
Kosinska, A. ; Kallin, A.* ; Protzer, U. & Knolle, P.A.*: Overcoming liver tolerance to clear persistent HBV infection. Hepatology 68, 334A-334A (2018)
5.
Manske, K.* et al.: Outcome of antiviral immunity in the liver is shaped by the level of antigen expressed in infected hepatocytes. Hepatology, DOI: 10.1002/hep.30080 (2018)
6.
Michler, T. et al.: Suppression of hepatitis B virus antigens by RNA interference enables therapeutic vaccination to achieve immune control in high-titer virus carriers. Hepatology 68, 49A-50A (2018)
7.
von Loeffelholz, C.* & Birkenfeld, A.L.: Reply. Hepatology 67, 452-453 (2018)
8.
von Loeffelholz, C.* et al.: The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism. Hepatology 66, 616-630 (2017)
9.
Zhang, W.* et al.: PRMT5 restricts hepatitis B virus replication via epigenetic repression of cccDNA transcription and interference with pgRNA encapsidation. Hepatology 66, 398-415 (2017)
10.
Koppe, C.* et al.: IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. Hepatology 64, 1217-1231 (2016)
11.
Koppe, C.* et al.: A new molecular interaction between IKK alpha/beta and RIPK1 regulates biliary homeostasis and hepatocarcinogenesis. Hepatology 63, 1, 257A-258A (2016)
12.
Li, Y.* et al.: IFN-alpha-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection. Hepatology 63, 1, 921A-921A (2016)
13.
Matter, M.S.* et al.: Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype. Hepatology 63, 1888-1899 (2016)
14.
Sunami, Y.* et al.: Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR. Hepatology 63, 1592-1607 (2016)
15.
Sunami, Y.* et al.: Canonical NF-kappa B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 63, 1, 233A-233A (2016)
16.
Thomsen, M.K.* et al.: Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection. Hepatology 64, 746-759 (2016)
17.
Endig, J.* et al.: CD8+ T-cells drive liver injury and hepatocellular carcinoma in chronic liver disease. Hepatology 62, 1244A (2015)
18.
Li, Y.* et al.: IFN-α-mediated base excision repair pathway correlates with antiviral response against Hepatitis B Virus infection. Hepatology 62, 1030A (2015)
19.
Seubert, B.* et al.: TIMP-1 creates a pre-metastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology 61, 238-248 (2015)
20.
Hösel, M.* et al.: Hepatitis B virus infection enhances susceptibility towards adeno-associated viral vector transduction in vitro and in vivo. Hepatology 59, 2110-2120 (2014)